Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

457 Views

I4. New vaccines

Poster Session: New Vaccines

(P-607) Immunogenicity and Tolerability of the Novavax Nanoparticle Influenza Vaccine (NIV) and COVID-Influenza Combination Vaccine (CIC)

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Vivek Shinde, MD, MPH

Vice President
Novavax
Gaithersburg, Maryland, United States

Co-Author(s)

SN

Susan Neal, n/a

Novavax
Gaithersburg, Maryland, United States
JP

Joyce S. Plested, n/a

Senior Director, Clinical Immunology
Novavax
Gaithersburg, Maryland, United States
TV

Tim Vincent, n/a

Novavax
Gaithersburg, Maryland, United States
MZ

Mingzhu Zhu, n/a

Principle Scientist
Novavax
Gaithersburg, Maryland, United States
SC

Shane Cloney-Clark, n/a

Associate Director
Novavax
Gaithersburg, Maryland, United States
ZC

Zhaohui Cai, PhD

Novavax, Inc.
Gaithersburg, Maryland, United States
BR

Bridget Riviers, Ph.D.

Novavax, Inc.
Gaithersburg, Maryland, United States
FM

Farnaz Mahkhou, Ph.D.

Novavax, Inc.
Gaithersburg, Maryland, United States
AM

Anthony M. Marchese, PhD

Senior Manager, Medical Affairs
Novavax, Inc.
Gaithersburg, Maryland, United States
IC

Iksung Cho, MS

Vice President, Biostatistics
Novavax, Inc.
Gaithersburg, Maryland, United States
LF

Louis F. Fries, III, MD

Senior Vice President and Chief Medical Officer
Novavax, Inc.
Gaithersburg, MD, United States
WW

Wayne Woo, MS

Novavax, Inc.
Gaithersburg, Maryland, United States